This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 May;12(5):343.

doi: 10.1038/nrd4014.

Tumour vaccination: Devil in the details of adjuvant choice

Alexandra Flemming

PMID: 23629498
DOI: 10.1038/nrd4014

Comment

Tumour vaccination: Devil in the details of adjuvant choice

Alexandra Flemming. Nat Rev Drug Discov. 2013 May.

. 2013 May;12(5):343.

doi: 10.1038/nrd4014.

Author

Alexandra Flemming

PMID: 23629498
DOI: 10.1038/nrd4014

No abstract available

PubMed Disclaimer

Comment on

Persistent antigen at vaccination sites induces tumor-specific CD8⁺ T cell sequestration, dysfunction and deletion.
Hailemichael Y, Dai Z, Jaffarzad N, Ye Y, Medina MA, Huang XF, Dorta-Estremera SM, Greeley NR, Nitti G, Peng W, Liu C, Lou Y, Wang Z, Ma W, Rabinovich B, Sowell RT, Schluns KS, Davis RE, Hwu P, Overwijk WW. Hailemichael Y, et al. Nat Med. 2013 Apr;19(4):465-72. doi: 10.1038/nm.3105. Epub 2013 Mar 3. Nat Med. 2013. PMID: 23455713 Free PMC article.

References

1. Nat Med. 2013 Apr;19(4):465-72 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Other Literature Sources
- scite Smart Citations